Treść książki
Przejdź do opcji czytnikaPrzejdź do nawigacjiPrzejdź do informacjiPrzejdź do stopki
ExperimentalEyeResearch2013;107:52-58.
27.OnkenM.D.,WorleyL.A.,EhlersJ.P
.iwsp.:Geneexpressionprofilinginuveal
melanomarevealstwomolecularclassesandpredictsmetastaticdeath.CancerResearch2004;64:7205-7209.
28.HarbourJ.W.,
OnkenM.D.,RobersonE.D.iwsp.:FrequentmutationofBAP1inmetastasizinguvealmelanomas.Science2010;330:1410-1413.
29.BronkhorstI.H.,VuT.H.,JordanovaE.S.iwsp.:Diferentsubsetsoftumor-infiltratinglymphocytescorrelatewithmacrophageinfux
andmonosomy3inuvealmelanoma.InvestigativeOphthalmology&VisualScience2012;53(9):5370-5378.
30.GezginG.,Dogru-
sözM.,VanEssenT.H.iwsp.:Geneticevolutionofuvealmelanomaguidesthedevelopmentofaninfammatorymicroenvironment.
CancerImmunology.Immunotherapy2017;66:903-912.
31.LiuJ.,LiF.,PingY.iwsp.:LocalproductionofthechemokinesCCL5andCXCL10attractsCD8+Tlymphocytesintoeso-
phagealsquamouscellcarcinoma.Oncotarget2015;6:24978-24989.
32.LiH.,AlizadehH.,NiederkornJ.Y.:Diferentialexpres-
sionofchemokinereceptorsonuvealmelanomacellsandtheirmetastases.InvestigativeOphthalmology&VisualScience2008;49:
636-643.
33.LiH.,YangW.,ChenP.W.iwsp.:InhibitionofchemokinereceptorexpressiononuvealmelanomasbyCXCR4siRNAand
itsefectonuvealmelanomalivermetastases.InvestigativeOphthalmology&VisualScience2009;50:5522-5528.
34.DeLange
M.J.,VanPeltS.I.,VersluisM.iwsp.:Heterogeneityrevealedbyintegratedgenomicanalysisuncoversamolecularswitchinmalignant
uvealmelanoma.Oncotarget2015;6(35):37824-37835.
35.RobertsonA.G.,ShihJ.,YauC.iwsp.:Integrativeanalysisidentifiesfour
molecularandclinicalsubsetsinuvealmelanoma.CancerCell2017;32(2):204-220.
36.Royer-BertrandB.,TorselloM.,RimoldiD.
iwsp.:Comprehensivegeneticlandscapeofuvealmelanomabywhole-genomesequencing.AmericanJournalofHumanGenetics
2016;99(5):1190-1198.
37.HanahanD.,WeinbergR.A.:Hallmarksofcancer:thenextgeneration.Cell2011;144(5):646-674.
38.LyL.V.,BaghatA.,VersluisM.iwsp.:Inagedmice,outgrowthofintraocularmelanomadependsonproangiogenicM2typema-
crophages.JournalofImmunology2010;185:3481-3488.
39.ThorssonV.,GibbsD.L.,BrownS.D.iwsp.:Theimmunelandscapeof
cancer.Immunity2018;48:1-19.
40.KrishnaY.,McCarthyC.,KaliraiH.iwsp.:Infammatorycellinfiltratesinadvancedmetastatic
uvealmelanoma.HumanPathology2017;66:159-166.
41.VanRaamsdonkC.D.,GriewankK.G.,CrosbyM.B.iwsp.:MutationsinGNA11inuvealmelanoma.NewEnglandJournal
ofMedicine2010;363:2191-2199.
42.SpendloveH.E.,DamatoB.E.,HumphreysJ.iwsp.:BRAFmutationsaredetectableincon-
junctivalbutnotuvealmelanomas.MelanomaResearch2004;14:449-452.
43.GriewankK.G.,WestekemperH.,MuraliR.iwsp.:
ConjunctivalmelanomasharborBRAFandNRASmutationsandcopynumberchangessimilartocutaneousandmucosalmelanomas.
ClinicalCancerResearch2013;19(12):3143-3152.
44.CaoJ.,BrouwerN.J.,RichardsK.E.iwsp.:PD-L1/PD-1expressionandtumor-
-infiltratinglymphocytesinconjunctivalmelanoma.Oncotarget2017;8(33):54722-54734.
45.TuomaalaS.,ToivonenP.,Al-JamalR.
iwsp.:PrognosticsignificanceofhistopathologyofprimaryconjunctivalmelanomainCaucasians.CurrentEyeResearch2007;32(11):
939-952.
46.CaoJ.,HeijkantsR.C.,JochemsenA.G.iwsp.:TargetingoftheMAPKandAKTpathwaysinconjunctivalmelanoma
showspotentialsynergy.Oncotarget2016;8(35):58021-58036.
47.YangW.,LiH.,ChenP.W.iwsp.:PD-L1expressiononhuman
ocularcellsanditspossibleroleinregulatingimmune-mediatedocularinfammation.InvestigativeOphthalmology&VisualScience
2009;50(1):273-280.
48.PapavasileiouE.,PrasadS.,FreitagS.K.iwsp.:Ipilimumab-inducedocularandorbitalinfammation-Acase
seriesandreviewoftheliterature.OcularImmunologyandInfammation2016;24(2):140-146.
49.BrouwerN.J.,HaanenJ.B.A.G.,
JagerM.J.:Developmentofocularrosaceafollowingcombinedipilimumabandnivolumabtreatmentformetastaticmalignantskin
melanoma.OcularOncologyandPathology2017;3:188-192.
34
Immunologianowotworówoka
